Lindy K. Alles

443 total citations
16 papers, 351 citations indexed

About

Lindy K. Alles is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Lindy K. Alles has authored 16 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Lindy K. Alles's work include Liver Disease Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Neuroblastoma Research and Treatments (4 papers). Lindy K. Alles is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Neuroblastoma Research and Treatments (4 papers). Lindy K. Alles collaborates with scholars based in Netherlands, Australia and Switzerland. Lindy K. Alles's co-authors include Thomas M. van Gulik, Michal Heger, Mans Broekgaarden, Ruud Weijer, Joanne Verheij, Milan Kos, Eszter Hazai, Zsolt Bikádi, Allard C. van der Wal and Rowan F. van Golen and has published in prestigious journals such as Cancer Research, Annals of Surgery and Scientific Reports.

In The Last Decade

Lindy K. Alles

16 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindy K. Alles Netherlands 10 118 96 88 77 71 16 351
Julia Brangsch Germany 12 57 0.5× 49 0.5× 157 1.8× 35 0.5× 27 0.4× 35 326
Banghao Xu China 10 35 0.3× 94 1.0× 71 0.8× 51 0.7× 115 1.6× 30 328
Mau‐Shin Chi Taiwan 9 81 0.7× 117 1.2× 62 0.7× 63 0.8× 62 0.9× 17 327
Goran H. Mohammad United Kingdom 9 34 0.3× 115 1.2× 52 0.6× 96 1.2× 64 0.9× 10 329
Chang Hong China 12 50 0.4× 123 1.3× 27 0.3× 60 0.8× 68 1.0× 35 316
Ningyang Jia China 13 76 0.6× 39 0.4× 156 1.8× 50 0.6× 98 1.4× 39 495
Masakazu Kojika Japan 6 60 0.5× 121 1.3× 128 1.5× 43 0.6× 142 2.0× 8 328
Zhi‐Cheng Jin China 11 27 0.2× 45 0.5× 68 0.8× 29 0.4× 54 0.8× 19 298
Xiaohui Qian China 10 28 0.2× 119 1.2× 68 0.8× 55 0.7× 71 1.0× 23 274

Countries citing papers authored by Lindy K. Alles

Since Specialization
Citations

This map shows the geographic impact of Lindy K. Alles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindy K. Alles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindy K. Alles more than expected).

Fields of papers citing papers by Lindy K. Alles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindy K. Alles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindy K. Alles. The network helps show where Lindy K. Alles may publish in the future.

Co-authorship network of co-authors of Lindy K. Alles

This figure shows the co-authorship network connecting the top 25 collaborators of Lindy K. Alles. A scholar is included among the top collaborators of Lindy K. Alles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindy K. Alles. Lindy K. Alles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Eleveld, Thomas F., Linda Schild, Lindy K. Alles, et al.. (2023). MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma. Frontiers in Oncology. 13. 1130034–1130034. 6 indexed citations
3.
Bate-Eya, Laurel T., Lindy K. Alles, Linda Schild, et al.. (2021). High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells. Molecular Cancer Therapeutics. 20(6). 1161–1172. 9 indexed citations
4.
Schild, Linda, Kaylee M. Keller, Lindy K. Alles, et al.. (2020). Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses. European Journal of Cancer. 142. 1–9. 9 indexed citations
5.
Vogel, Jantien A., Eran van Veldhuisen, Lindy K. Alles, et al.. (2019). Time-Dependent Impact of Irreversible Electroporation on Pathology and Ablation Size in the Porcine Liver: A 24-Hour Experimental Study. Technology in Cancer Research & Treatment. 18. 1078144547–1078144547. 18 indexed citations
6.
Golen, Rowan F. van, Megan J. Reiniers, Gerben Marsman, et al.. (2019). The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1192–1200. 26 indexed citations
7.
Eleveld, Thomas F., Linda Schild, Jan Köster, et al.. (2018). RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma. Cancer Research. 78(21). 6297–6307. 40 indexed citations
8.
Golen, Rowan F. van, Pim B. Olthof, Megan J. Reiniers, et al.. (2018). FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis. Scientific Reports. 8(1). 16529–16529. 29 indexed citations
9.
Reiniers, Megan J., Ruud Weijer, Jimme K. Wiggers, et al.. (2018). Effect of preoperative biliary drainage on cholestasis-associated inflammatory and fibrotic gene signatures in perihilar cholangiocarcinoma. British journal of surgery. 106(1). 55–58. 1 indexed citations
10.
Heger, Michal, Rowan F. van Golen, Lindy K. Alles, et al.. (2016). Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport. Scientific Reports. 6(1). 31829–31829. 15 indexed citations
11.
Broekgaarden, Mans, Ruud Weijer, Milan Kos, et al.. (2016). Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes. Nano Research. 9(6). 1639–1662. 85 indexed citations
12.
Olthof, Pim B., Megan J. Reiniers, Milan Kos, et al.. (2015). IL-23 and IL-17 are not involved in hepatic ischemia reperfusion injury in mouse and man. Journal of Clinical and Translational Research. 4 indexed citations
13.
Weijer, Ruud, Mans Broekgaarden, Lindy K. Alles, et al.. (2015). Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. Oncotarget. 7(3). 3341–3356. 53 indexed citations
14.
Olthof, Pim B., Rowan F. van Golen, Megan J. Reiniers, et al.. (2015). IL-23 and IL-17A are not involved in hepatic/ischemia reperfusion injury in mouse and man.. PubMed. 1(3). 180–189. 8 indexed citations
15.
Heger, Michal, Rowan F. van Golen, Lindy K. Alles, et al.. (2014). Reduction of Cardiac Cell Death after Helium Postconditioning in Rats: Transcriptional Analysis of Cell Death and Survival Pathways. Molecular Medicine. 20(1). 516–526. 21 indexed citations
16.
Esschert, Jacomina W. van den, Krijn P. van Lienden, Lindy K. Alles, et al.. (2012). Liver Regeneration After Portal Vein Embolization Using Absorbable and Permanent Embolization Materials in a Rabbit Model. Annals of Surgery. 255(2). 311–318. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Brangsch Breakdown of academic impact, for papers by Banghao Xu Breakdown of academic impact, for papers by Mau‐Shin Chi Breakdown of academic impact, for papers by Goran H. Mohammad Breakdown of academic impact, for papers by Chang Hong Breakdown of academic impact, for papers by Ningyang Jia Breakdown of academic impact, for papers by Masakazu Kojika Breakdown of academic impact, for papers by Zhi‐Cheng Jin Breakdown of academic impact, for papers by Xiaohui Qian
Rankless by CCL
2026